Chronic lung diseases: prospects for regeneration and repair.
Journal Information
Full Title: Eur Respir Rev
Abbreviation: Eur Respir Rev
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Pulmonary Medicine
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Conflict of interest: P.J. Barnes reports grants and personal fees from AstraZeneca and Boehringer Ingelheim, and personal fees from Novartis, Teva and Pieris, outside the submitted work.: Conflict of interest: G.P. Anderson served on secondment as Chief Scientist in the Respiratory, Inflammation and Autoimmune division of AstraZeneca in 2016.: Conflict of interest: M. Fagerås is an employee of AstraZeneca.: Conflict of interest: M.G. Belvisi reports personal fees from AstraZeneca, during the conduct of the study."
"Support statement: The development of this article was funded by AstraZeneca, Cambridge, UK."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025